RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.55

EPS Forecast

$142.6

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon
NKTRNektar TherapeuticsALKSAlkermes PlcBMRNBiomarin Pharmaceutical IncPAHCPhibro Animal Health CorpJAZZJazz Pharmaceuticals PlcALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncSRPTSarepta Therapeutics IncSAGESage Therapeutics Inc